原田 浩之 はらだ ひろゆき 先生

Tanaka K, Harada H, Kayamori K, Omura K. Chronic sclerosing sialadenitis of the submandibular gland as the initial symptom of IgG4-related disease: a case report. Tohoku J Exp Med. 2015.07; 236 (3): 193-198.

Haobam Bijaya, Nozawa Takashi, Minowa-Nozawa Atsuko, Tanaka Misako, Oda Seiichiro, Watanabe Takayasu, Aikawa Chihiro, Maruyama Fumito, Nakagawa Ichiro. Rab17-mediated recycling endosomes contribute to autophagosome formation in response to Group A Streptococcus invasion. Cell Microbiol. 2014.12; 16 (12): 1806-1821.

Mochizuki Yumi, Omura Ken, Harada Hiroyuki, Marukawa Eriko, Shimamoto Hiroaki, Tomioka Hirofumi. Functional outcomes and patient satisfaction after vascularized osteocutaneous scapula flap reconstruction of the mandible in patients with benign or cancerous tumours. Int J Oral Maxillofac Surg. 2014.11; 43 (11): 1330-1338.

Kudoh Masanori, Harada Hiroyuki, Matsumoto Koshi, Sato Yuriko, Omura Ken, Ishii Yoshimasa. Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014.10; 118 (4): e105-e110.

Takahara Namiaki, Imai Hideki, Nakagawa Satoshi, Sumikura Kanako, Tsushima Fumihiko, Omura Ken. Temporomandibular joint intermittent closed lock: clinic and magnetic resonance imaging findings. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014.10; 118 (4): 418-423.

Shirakawa Jumpei, Ezura Yoichi, Moriya Shuichi, Kawasaki Makiri, Yamada Takayuki, Notomi Takuya, Nakamoto Tetsuya, Hayata Tadayoshi, Miyawaki Atsushi, Omura Ken, Noda Masaki. Migration linked to FUCCI-indicated cell cycle is controlled by PTH and mechanical stress. J Cell Physiol. 2014.10; 229 (10): 1353-1358.

Mochizuki Yumi, Omura Ken, Harada Hiroyuki, Marukawa Eriko, Shimamoto Hiroaki, Tomioka Hirofumi. Functional outcomes with dental prosthesis following simultaneous mandibulectomy and mandibular bone reconstruction. J Prosthodont Res. 2014.10; 58 (4): 259-266.

Omura Ken. Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma. Int J Clin Oncol. 2014.06; 19 (3): 423-430.

Matsukawa Sho, Morita Kei-ichi, Negishi Ayako, Harada Hiroyuki, Nakajima Yusuke, Shimamoto Hiroaki, Tomioka Hirofumi, Tanaka Kae, Ono Masaya, Yamada Tesshi, Omura Ken. Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma. Cancer Med. 2014.04; 3 (2): 349-361.

Yamamoto Shinsuke, Inoue Jun, Kawano Tatsuyuki, Kozaki Ken-ichi, Omura Ken, Inazawa Johji. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors. Mol Cancer Res. 2014.01; 12 (1): 58-68.

Rushatamukayanunt Pradit, Morita Kei-ichi, Matsukawa Sho, Harada Hiroyuki, Shimamoto Hiroaki, Tomioka Hirofumi, Omura Ken. Lack of association between high-risk human papillomaviruses and oral squamous cell carcinoma in young Japanese patients. Asian Pac J Cancer Prev. 2014; 15 (10): 4135-4141.

Kudoh Masanori, Harada Hiroyuki, Sato Yuriko, Omura Ken, Ishii Yoshimasa. A case of Basal cell adenoma of the upper lip. Case Rep Med. 2014; 2014 795356.

Kudoh Masanori, Harada Hiroyuki, Omura Ken, Ishii Yoshimasa. Epidermoid cyst arising in the submandibular region. Case Rep Med. 2013; 2013 419289.

Misako Tanaka, Hiroyuki Harada, Hiroshi Kimura. The role of H3K9me3 in oral squamous cell carcinoma. Biochem Biophys Res Commun. 2023.01; 640 56-63.

Kugimoto T, Yamagata Y, Ohsako T, Hirai H, Nishii N, Kayamori K, Ikeda T, Harada H.. Massive low-grade myxoid liposarcoma of the floor of the mouth: A case report and review of literature. World J Clin Cases. 2022.12; 10 (34): 12742-12749.

Ohyama Y, Yamashiro M, Michi Y, Uzawa N, Myo K, Sonoda I, Sumino J, Miura C, Mizutani M, Yamamoto D, Kayamori K, Yoda T. Determination of Significant Prognostic Factors for Maxillary Gingival Squamous Cell Carcinoma in 90 Cases Indian J Otolaryngol Head Neck Surg. 2022.12; 74 (3): 5930-5935.

Machitani M, Takei J, Kaneko MK, Ueki S, Ohashi H, Watashi K, Kato Y, Masutomi K. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2 Virol J. 2022.12; 19 (1): 213.

Nojima H, Kaida A, Harada H, Akiyama M, Miuraa M. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model Radiat Res. 2022.12; 198 (6): 632-638.

Hirai H, Kayamori K, Noji R, Kuroshima T, Ikeda T, Harada H. A rare case of solitary intraoral superficial angiomyxoma arising in the soft palate. J Oral Sci. 2022.11;

Tsukamoto K, Tanahashi A, Harada H, Takaoka M, Sohara H. Development of a new HotBalloon™ ablation catheter equipped with a balloon surface temperature monitoring sensor for pulmonary vein isolation. J Med Eng Technol. 2022.11; 46 (8): 687-692.

Nojima H, Kaida A, Kuroshima T, Yoshimura RI, Miura M. Retrograde Migration of an Au-198 Grain to the Submandibular Gland Post Brachytherapy Treatment of Floor of Mouth Cancer Cureus. 2022.11; 14 (11): e31904.

Nishii N, Hirotsu Y, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M. Observation of dynamic changes in neutrophil-to-lymphocyte ratio is useful for evaluating treatment response to nivolumab in PD-L1-negative advanced oral cancer J Oral Maxillofac Surg Med Pathol. 2022.11; 34 (6): 833-841.

Takuya Komiyama, Takeshi Kuroshima, Takehito Sugasawa, Shin-Ichiro Fujita, Yuta Ikami, Hideaki Hirai, Fumihiko Tsushima, Yasuyuki Michi, Kou Kayamori, Fumihiro Higashino, Hiroyuki Harada. High expression of Sam68 contributes to metastasis by regulating vimentin expression and a motile phenotype in oral squamous cell carcinoma. Oncol Rep. 2022.10; 48 (4): 183.

Nojima H, Kaida A, Harada H, Akiyama M, Miuraa M. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model. Radiat Res. . 2022.10;

Yanamoto S, Michi Y, Otsuru M, Inomata T, Nakayama H, Nomura T, Hasegawa T, Yamamura Y, Yamada SI, Kusukawa J, Yamakawa N, Hasegawa O, Ueda M, Kitagawa Y, Hiraki A, Hasegawa T, Ohiro Y, Kobayashi W, Asoda S, Kobayashi T, Iino M, Fukuda M, Ishibashi-Kanno N, Kawaguchi K, Aijima R, Noguchi K, Okura M, Tanaka A, Sugiura T, Shintani Y, Yagihara K, Yamashiro M, Ota Y, Miyazaki A, Takeshita A, Kawamata H, Hiroshi I, Uchida K, Umeda M, Kurita H, Kirita T. Protocol for a multicentre, prospective observational study of elective neck dissection for clinically node-negative oral tongue squamous cell carcinoma (END-TC study) BMJ Open. 2022.09; 12 (9): e059615.

Tsushima F, Sakurai J, Shimizu R, Kayamori K, Harada H. Oral lichenoid contact lesions related to dental metal allergy may resolve after allergen removal. J Dent Sci. 2022.07; 17 (3): 1300-1306.

Rika Noji, Kohki Tohyama, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Akihisa Tasaki, Kazuchika Ohno, Yosuke Ariizumi, Iichiroh Onishi, Mitsukuni Suenaga, Takehiko Mori, Ryuichi Okamoto, Ryoichi Yoshimura, Masahiko Miura, Takahiro Asakage, Satoshi Miyake, Sadakatsu Ikeda, Hiroyuki Harada, Yoshihito Kano. Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer. Cancers (Basel). 2022.07; 14 (14): 3476.

Xie CY, Satake-Ozawa M, Rashed F, Khan M, Ikeda M, Hayashi S, Sawada S, Sasaki Y, Ikeda T, Mori Y, Akiyoshi K, Aoki K. Perforated Hydrogels Consisting of Cholesterol-Bearing Pullulan (CHP) Nanogels: A Newly Designed Scaffold for Bone Regeneration Induced by RANKL-Binding Peptides and BMP-2 Int J Mol Sci. 2022.07; 23 (14): 7768.

Okuyama K, Yanamoto S. TMEM16A as a potential treatment target for head and neck cancer J Exp Clin Cancer Res. 2022.06; 41 (1): 196.

Hiromitsu Sato, Peng Chen, Maki Ashida, Yusuke Tsutsumi, Hiroyuki Harada, Takao Hanawa. Evaluation of cytocompatibility and osteoconductivity of Zr-14Nb-5Ta-1Mo alloy with MC3T3-E1 cells. Dent Mater J. 2022.05;

Harazono Y, Kayamori K, Sakamoto J, Akaike Y, Kurasawa Y, Tsushima F, Sasaki Y, Harada H, Yoda T. Retrospective analysis of schwannoma in the oral and maxillofacial region: clinicopathological characteristics and specific pathology of ancient change. Br J Oral Maxillofac Surg. 2022.04; S0266-4356 (21): 00262-X.

Nanamiya R, Suzuki H, Takei J, Li G, Goto N, Harada H, Saito M, Tanaka T, Asano T, Kaneko MK, Kato Y. Development of Monoclonal Antibody 281-mG 2a-f Against Golden Hamster Podoplanin. Monoclon Antib Immunodiagn Immunother. 2022.04;

Li G, Suzuki H, Takei J, Asano T, Sano M, Tanaka T, Harada H, Mizuno T, Ohishi T, Kawada M, Kaneko MK, Kato Y. Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf). Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2): 53-58.

Goto N, Suzuki H, Ohishi T, Harakawa A, Li G, Saito M, Takei J, Tanaka T, Asano T, Sano M, Kawada M, Kaneko MK, Kato Y. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Anti-EGFR Monoclonal Antibody Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2): 67-73.

Widyagarini A, Nishii N, Kawano Y, Zhang C, Azuma M. VSIG4/CRIg directly regulates early CD8+T cell activation through its counter-receptor in a narrow window Biochem Biophys Res Commun. 2022.04; 614 100-106.

Takei J, Suzuki H, Asano T, Tanaka T, Kaneko MK, Kato Y. Development of a Novel Anti-mouse CCR4 Monoclonal Antibody (C4Mab-1) by N-terminal Peptide Immunization Monoclon Antib Immunodiagn Immunother. 2022.04; 41 (2):

Tran PX, Inoue J, Harada H, Inazawa J. Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma. Mol Ther Oncolytics. 2022.03; 24 897-908.

Matsuda Y, Yamashita T, Ye J, Yasukawa M, Yamakawa K, Mukai Y, Machitani M, Daigo Y, Miyagi Y, Yokose T, Oshima T, Ito H, Morinaga S, Kishida T, Minamoto T, Yamada S, Takei J, Kaneko MK, Kojima M, Kaneko S, Masaki T, Hirata M, Haba R, Kontani K, Kanaji N, Miyatake N, Okano K, Kato Y, Masutomi K. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs J Pathol. 2022.03; 257 (2): 172-185.

Kaho Takada, Tomoki Chiba, Takayuki Miyazaki, Lisa Yagasaki, Ryo Nakamichi, Takanori Iwata, Keiji Moriyama, Hiroyuki Harada, Hiroshi Asahara. Single Cell RNA Sequencing Reveals Critical Functions of Mkx in Periodontal Ligament Homeostasis Front Cell Dev Biol. 2022.02; 10 795441.

Li G, Suzuki H, Takei J, Saito M, Goto N, Uchida K, Nakagawa T, Harada H, Tanaka T, Asano T, Kaneko MK, Kato Y.. Immunohistochemical Analysis Using Monoclonal Antibody PMab-269 Against Steller Sea Lion Podoplanin. Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1): 39-44.

Kawabata H, Suzuki H, Takei J, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD10 Monoclonal Antibody (MME/1870) using Enzyme-Linked Immunosorbent Assay Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1):

Nanamiya R, Takei J, Ohishi T, Asano T, Tanaka T, Sano M, Nakamura T, Yanaka M, Handa S, Tateyama N, Harigae Y, Saito M, Suzuki H, Kawada M, Kaneko MK, Kato Y. Defucosylated Anti-EGFR Monoclonal Antibody (134-mG2a-f) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma Monoclon Antib Immunodiagn Immunother. 2022.02; 41 (1):

Rika Noji, Yoshihito Kano, Hideaki Hirai, Iichiroh Onishi, Naoto Nishii, Ryoichi Yoshimura, Satoshi Miyake, Sadakatsu Ikeda, Hiroyuki Harada. MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma. Oral Oncol. 2022.01; 124 105666.

Yumi Mochizuki, Maiko Tsuchiya, Jun Oyama, Akane Wada, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Hiroyuki Harada, Tohru Ikeda, Takumi Akashi. Left supraclavicular (Virchow's) node metastasis detected before primary infradiaphragmatic tumor: a case series. J Med Case Rep. 2022.01; 16 (1): 33.

Shimizu R, Tsushima F, Komiya R, Yamagata Y, Harada H. Fixed Drug Eruption Associated with Nonsteroidal Anti-Inflammatory Drugs for Menstrual Pain: A Case Report. Case Rep Dermatol. 2022.01; 14 (1): 6-11.

Yasuyuki Michi, Hiroyuki Harada, Yu Oikawa, Kohei Okuyama, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Yumi Mochizuki, Hiroaki Shimamoto, Hirofumi Tomioka, Hirokazu Kachi, Jun-Ichiro Sakamoto, Kou Kayamori, Tetsuya Yoda. Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective study. BMC Oral Health. 2022.01; 22 (1): 20.

Tsushima F, Sakurai J, Shimizu R, Harada H. A case report of oral lichenoid lesions related to cross-reactivity between nickel and palladium. Contact Derm. 2021.12; 85 (6): 700-701.

Asano T, Takei J, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-HER2 Monoclonal Antibody (H2Mab-181) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 255-260.

Asano T, Takei J, Furusawa Y, Saito M, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C20Mab-60) using the HisMAP Method. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 243-249.

Li G, Ohishi T, Kaneko MK, Takei J, Mizuno T, Kawada M, Saito M, Suzuki H, Kato Y. Defucosylated Mouse–Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors. Cells. 2021.12; 10 (12): 3599.

Takei J, Asano T, Li G, Saito M, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-Human CCR9 Monoclonal Antibody (C9Mab-1) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 239-242.

Yoshimura R, Toda K, Watanabe H, Kaida A, Harada H, Asakage T, Miura M. Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer. Anticancer Res. 2021.12; 41 (12): 6259-6266.

Terasawa K, Kato Y, Ikami Y, Sakamoto K, Ohtake K, Kusano S, Tomabechi Y, Kukimoto-Niino M, Shirouzu M, Guan JL, Kobayashi T, Iwata T, Watabe T, Yokoyama S, Hara-Yokoyama M. Direct homophilic interaction of LAMP2A with the two-domain architecture revealed by site-directed photo-crosslinks and steric hindrances in mammalian cells. Autophagy. 2021.12; 17 (12): 4286-4303.

Shimono H, Hirai H, Oikawa Y, Mochizuki Y, Kuroshima T, Tomioka H, Kayamori K, Ikeda T, Harada H. Metastatic tumors in the oral region: a retrospective chart review of clinical characteristics and prognosis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.12; 132 (6): 648-652.

Takei J, Suzuki H, Asano T, Li G, Saito M, Kaneko MK, Kato Y. Epitope Mapping of an Anti-CD20 Monoclonal Antibody (C20Mab-60) using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother. 2021.12; 40 (6): 250-254.

Yuta Ikami, Kazue Terasawa, Kensaku Sakamoto, Kazumasa Ohtake, Hiroyuki Harada, Tetsuro Watabe, Shigeyuki Yokoyama, Miki Hara-Yokoyama. The two-domain architecture of LAMP2A regulates its interaction with Hsc70. Exp Cell Res. 2021.12; 411 (1): 112986.

Okuyama K, Michi Y, Kashima Y, Tomioka H, Hirai H, Yokokawa M, Yamagata Y, Kuroshima T, Sato Y, Tsuchiya M, Kayamori K, Ikeda T, Harada H. Epithelial-Myoepithelial Carcinoma of the Minor Salivary Glands: Case Series with Comprehensive Review. Diagnostics. 2021.11; 11 (11): 2124.

ティーラウォン・チャンヤーヌット, 坂本 啓, 布川裕規, 土谷麻衣子, 栢森 高, 明石 巧, 濱垣美和子, 富岡博文, 黒嶋雄志, 森田圭一, 原田浩之, 池田 通. 舌癌症例にみられるヒトパピローマウイルス(HPV)感染と無関係なp16免疫染色陽性反応. 口腔病学会雑誌. 2021.11; 88 (2-3): 115-126.

Hayashi S, Sasaki Y, Kubo H, Sawada S, Kinoshita N, Marukawa E, Harada H, Akiyoshi K. Construction of Hybrid Cell Spheroids Using Cell Sized Cross-Linked Nanogel Microspheres as an Artificial Extracellular Matrix. ACS Appl Bio Mater. 2021.11; 4 (11): 7848-7855.

Okuyama K, Yanamoto S, Michi Y, Shibata E, Tsuchiya M, Yokokawa M, Naruse T, Tomioka H, Kuroshima T, Shimamoto H, Ikeda T, Umeda M, Yoda T, Harada H. Multicenter retrospective analysis of clinicopathological features and prognosis of oral tongue squamous cell carcinoma in adolescent and young adult patients. Medicine. 2021.10; 100 (41): e27560.

Harada H, Tomioka H, Hirai H, Kuroshima T, Oikawa Y, Nojima H, Sakamoto J, Kurabayashi T, Kayamori K, Ikeda T. MRI before biopsy correlates with depth of invasion corrected for shrinkage rate of the histopathological specimen in tongue carcinoma. Sci Rep. 2021.10; 11 (1): 20992.

Kuroshima T, Onozato Y, Oikawa Y, Ohsako T, Kugimoto T, Hirai H, Tomioka H, Michi Y, Miura M, Yoshimura R, Harada H. Prognostic impact of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue: a retrospective study. Sci Rep. 2021.10; 11 (1): 20535.

Terauchi M, Marukawa E, Hyodo K, Iwasaki T, Wada A, Harada H, Yoda T. Conservative surgical treatment of odontogenic myxoma with preservation of the inferior alveolar nerve. J Oral Maxillofac Surg Med Pathol. 2021.10;

Shibata E, Morita KI, Kayamori K, Tange S, Shibata H, Harazono Y, Michi Y, Ikeda T, Harada H, Imoto I, Yoda T. Detection of novel fusion genes by next-generation sequencing-based targeted RNA sequencing analysis in adenoid cystic carcinoma of head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.10; 132 (4): 426-433.

Takei J, Asano T, Suzuki H, Kaneko MK, Kato Y. Epitope mapping of the anti-CD44 monoclonal antibody (C44Mab-46) using alanine-scanning mutagenesis and surface plasmon resonance. Monoclon Antib Immunodiagn Immunother. 2021.10; 40 (5): 219-226.

Harada H, Shimamoto H, Oikawa Y, Kuroshima T, Tomioka H, Hirai H, Tsushima F, Michi Y. Mandibular Reconstruction with Scapular Systems: A Single-Center Case Series Involving 208 Flaps. Plast Reconstr Surg. 2021.09; 148 (3): 625-634.

Mochizuki Y, Marukawa E, Harada H, Kinoshita N, Nakatani R, Oikawa Y, Hirai H, Tomioka H, Yoda T, Nakamura S, Kurabayashi T. Postoperative morphological changes over time of vascularized scapular bone used for mandibular reconstruction: A retrospective cohort study. J Plast Reconstr Aesthet Surg. 2021.09; 74 (9): 1984-1990.

Kaida A, Yamamoto S, Parrales A, Young ED, Ranjan A, Alalem MA, Morita KI, Oikawa Y, Harada H, Ikeda T, Thomas SM, Diaz FJ, Iwakuma T. DNAJA1 promotes cancer metastasis through interaction with mutant p53. Oncogene. 2021.08; 40 (31): 5013-5025.

Asano T, Ohishi T, Takei J, Nakamura T, Nanamiya R, Hosono H, Tanaka T, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y. Anti-HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma. Oncol Rep. 2021.08; 46 (2): 173.

Asano T, Kaneko MK, Takei J, Tateyama N, Kato Y. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C44Mab-46) Using the REMAP Method. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 156-161.

Tanaka T, Asano T, Sano M, Takei J, Hosono H, Nanamiya R, Tateyama N, Kaneko MK, Kato Y. Epitope Mapping of the Anti-California Sea Lion Podoplanin Monoclonal Antibody PMab-269 using Alanine-scanning Mutagenesis and ELISA. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 196-200.

Tateyama N, Nanamiya R, Ohishi T, Takei J, Nakamura T, Yanaka M, Hosono H, Saito M, Asano T, Tanaka T, Sano M, Kawada M, Kaneko MK, Kato Y. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG 2a-f Exerts Antitumor Activities in Mouse Xenograft Models of Dog Epidermal Growth Factor Receptor-Overexpressed Cells. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 177-183.

Takei J, Asano T, Tanaka T, Sano M, Hosono H, Nanamiya R, Tateyama N, Saito M, Suzuki H, Harada H, Kaneko MK, Kato Y. Development of a Novel Anti-HER2 Monoclonal Antibody H2Mab-181 for Gastric Cancer. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 168-176.

Tateyama N, Asano T, Ohishi T, Takei J, Hosono H, Nanamiya R, Tanaka T, Sano M, Saito M, Kawada M, Kaneko MK, Kato Y. An Anti‐HER2 Monoclonal Antibody H2Mab‐41 Exerts Antitumor Activities in Mouse Xenograft Model using Dog HER2‐overexpressed Cells. Monoclon Antib Immunodiagn Immunother. 2021.08; 40 (4): 184-190.

Aragaki T, Tomomatsu N, Michi Y, Hosaka H, Fukai Y, Iijima M, Yoda T. Ramucirumab-related Oral Pyogenic Granuloma: A Report of Two Cases. Intern Med. 2021.08; 60 (16): 2601-2605.

Okuyama K, Hayashida S, Rokutanda S, Kawakita A, Soutome S, Sawada S, Yanamoto S, Kojima Y, Umeda M. Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study. J Dent Sci. 2021.07; 16 (3): 885-890.

Tanaka T, Ohishi T, Asano T, Takei J, Nanamiya R, Hosono H, Sano M, Harada H, Kawada M, Kaneko MK, Kato Y. An anti-TROP2 monoclonal antibody TrMab-6 exerts antitumor activity in breast cancer mouse xenograft models. Oncol Rep. 2021.07; 46 (1): 132.

Fukuda S, Akiyama M, Niki Y, Kawatsura R, Harada H, Nakahama K. Inhibitory effects of miRNAs in astrocytes on C6 glioma progression via connexin 43. Mol Cell Biochem. 2021.07; 476 (7): 2623-2632.

Shiba T, Watanabe T, Komatsu K, Koyanagi T, Nemoto T, Ohsugi Y, Michi Y, Katagiri S, Takeuchi Y, Ishihara K, Iwata T. Non-surgical treatment for periodontitis and peri-implantitis: longitudinal clinical and bacteriological findings-A case report with a 7-year follow-up evaluation. SAGE Open Med Case Rep. 2021.07; 9 2050313X211029154.

Tsushima F, Sakurai J, Uesugi A, Oikawa Y, Ohsako T, Mochizuki Y, Hirai H, Kayamori K, Harada H. Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients. BMC Oral Health. 2021.06; 21 (1): 298.

Hosono H, Asano T, Takei J, Sano M, Tanaka T, Kaneko MK, Kato Y. Development of an Anti-Elephant Podoplanin Monoclonal Antibody PMab-265 for Flow cytometry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 141-145.

Tanaka T, Asano T, Sano M, Takei J, Hosono H, Nanamiya R, Nakamura T, Yanaka M, Harada H, Fukui M, Suzuki H, Uchida K, Nakagawa T, Kato Y, Kaneko MK. Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 124-133.

Asano A, Nanamiya R, Takei J, Nakamura T, Yanaka M, Hosono H, Tanaka T, Sano M, Kaneko MK, Kato Y. Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 107-112.

Oikawa Y, Tanaka K, Ohsako T, Kugimoto T, Kuroshima T, Hirai H, Tomioka H, Shimamoto H, Michi Y, Sakamoto K, Ikeda T, Harada H. Comparison of Clinicopathological Characteristics Between the Anterior and Posterior Type of Squamous Cell Carcinoma of the Floor of the Mouth: The Anterior Type Is a Risk Factor for Multiple Primary Cancer. Front Oncol. 2021.06; 11 682428.

Nanamiya R, Takei J, Asano T, Tanaka T, Sano M, Nakamura T, Yanaka M, Hosono H, Kaneko MK, Kato Y. Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 101-106.

Nanamiya R, Takei J, Asano T, Sano M, Tanaka T, Hosono H, Harada H, Sakai Y, Mizuno T, Suzuki H, Kaneko MK, Kato Y. Ferret Podoplanin is Detected by PMab-241 in Immunohistochemistry. Monoclon Antib Immunodiagn Immunother. 2021.06; 40 (3): 134-140.

Sawa Y, Ibaragi S, Okui T, Yamashita J, Ikebe T, Harada H. Expression of SARS-CoV-2 entry factors in human oral tissue. J Anat. 2021.06; 238 (6): 1341-1354.

Yu Oikawa, Takuma Kugimoto, Yoshihisa Kashima, Kohei Okuyama, Toshimitsu Ohsako, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Hiroaki Shimamoto, Yasuyuki Michi, Hiroyuki Harada. Surgical treatment for oral tongue squamous cell carcinoma: A retrospective study of 432 patients. Glob Health Med. 2021.06; 3 (3): 157-162.

Yokokawa M, Hirai H, Tran C. M, Fukuda S, Sakamoto K, Ikeda T, Harada H. Adenoid cystic carcinoma metastas E12:T13 ized from the maxilla to the mandible:A case report. J Oral Mxillofac Surg Med Pathol. 2021.05; 33 (3): 371-375.

Yamada I, Yohino N, Yokokawa M, Oikawa Y, Harada H, Hikishima K, Kurabayashi T, Saida Y, Tateishi U, Ohata Y. Diffusion tensor imaging of oral carcinoma: Clinical evaluation and comparison with histopathological findings. Magn Reson Imaging. 2021.04; 77 99-108.

Tran CM, Kuroshima T, Oikawa Y, Michi Y, Kayamori K, Harada H. Clinicopathological and immunohistochemical characteristics of pigmented oral squamous cell carcinoma. Oncol Lett. 2021.04; 21 (4): 339.

Tanaka T, Nanamiya R, Takei J, Nakamura T, Yanaka M, Hosono H, Sano M, Asano T, Kaneko MK, Kato Y. Development of Anti-Mouse CC chemokine receptor 8 Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.04; 40 (2): 65-70.

Takei J, Asano T, Nanamiya R, Nakamura T, Yanaka M, Hosono H, Tanaka T, Sano M, Kaneko MK, Harada H, Kato Y. Development of Anti-Human T-Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Monoclonal Antibodies for Flow Cytometry. Monoclon Antib Immunodiagn Immunother. 2021.04; 40 (2): 71-75.

Suga T, Tu TTH, Takenoshita M, Mikuzuki L, Umezaki Y, Shimamoto H, Michi Y, Hong C, Abiko Y, Ikeda T, Uzawa N, Harada H, Toyofuku A. Case Report: Hidden Oral Squamous Cell Carcinoma in Oral Somatic Symptom Disorder. Front Psychiatry. 2021.04; 12 651871.

Ota Y, Noguchi T, Ariji E, Fushimi C, Fuwa N, Harada H, Hayashi T, Hayashi R, Honma Y, Miura M, Mori T, Nagatsuka H, Okura M, Ueda M, Uzawa N, Yagihara K, Yagishita H, Yamashiro M, Yanamoto S, Kirita T. General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis. Int J Clin Oncol. 2021.04; 26 (4): 623-635.

Tomioka H, Yamagata Y, Oikawa Y, Ohsako T, Kugimoto T, Kuroshima T, Hirai H, Shimamoto H, Harada H. Risk factors for distant metastasis in locoregionally controlled oral squamous cell carcinoma: a retrospective study. Sci Rep. 2021.03; 11 (1): 5213.

Sayama Y, Kaneko MK, Takei J, Hosono H, Sano M, Asano T, Kato Y. Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysis. Biochem Biophys Rep. 2021.03; 25 100902.

Okuyama K, Naruse T, Yanamoto S, Hayashida S, Rokutanda S, Kawakita A, Furukawa K, Umeda M. Prodromal symptoms of streptococcal toxic shock syndrome caused by Group A Streptococcus in the head and neck region: a case report. J Oral Maxillofac Surg Med Pathol. 2021.03; 33 (2): 211-214.

Okuyama K, Suzuki K, Naruse T, Tsuchihashi H, Yanamoto S, Kaida A, Miura M, Umeda M, Yamashita S. Prolonged cetuximab treatment promotes p27Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma. Sci Rep. 2021.03; 11 5259.

Fukawa Y, Sakamoto K, Kugimoto T, Michi Y, Harada H, Yamamoto M, Kitagawa M, Ikeda T, Yamamoto K. Nodular lymphocyte-predominant Hodgkin lymphoma involving the hard palate. Pathol Int. 2021.03; 71 (3): 213-215.

Nishii N, Hirotsu Y, Koida N, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M. Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers. Anticancer Res. 2021.02; 41 (2): 1035-1040.

Baba S, Akashi T, Kayamori K, Ohuchi T, Ogawa I, Kubota N, Nakano K, Nagatsuka H, Hasegawa H, Matsuzaka K, Tomii S, Uchida K, Katsuta N, Sekiya T, Ando N, Miura K, Ishibashi H, Ariizumi Y, Asakage T, Michi Y, Harada H, Sakamoto K, Eishi Y, Okubo K, Ikeda T. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma. Pathol Int. 2021.02; 71 (2): 113-123.

Terauchi M, Michi Y, Hirai H, Sugiyama K, Wada A, Harada H, Yoda T. Prognostic factors in mucoepidermoid carcinoma of the minor salivary glands: A single-center retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021.01; 131 (2): 209-216.

Sakakitani S, Podyma-Inoue KA, Takayama R, Takahashi K, Ishigami-Yuasa M, Kagechika H, Harada H, Watabe T. Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells. Cancer Sci. 2021.01; 112 (1): 155-167.

Nishii N, Shimamoto H, Ohsako T, Yokokawa M, Sato Y, Ohata Y, Kayamori K, Ikeda T, Harada H. Renal cell carcinoma metastasis to the maxillary bone successfully treated with surgery after vascular embolization: a case report J Med Case Rep. 2020.12; 14 (1): 193.

Hosono H, Ohishi T, Takei J, Asano T, Sayama Y, Kawada M, Kaneko MK, Kato Y. The anti-epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab-16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma Oncol Lett. 2020.12; 20 (6): 383.

Kaneko MK, Ohishi T, Takei J, Sano M, Nakamura T, Hosono H, Yanaka M, Asano T, Sayama Y, Harada H, Kawada M, Kato Y. The Anti-EpCAM monoclonal antibody (EpMab-16) exerts anti-tumor activity against oral squamous cell carcinomas Oncol Rep. 2020.12; 44 (6): 2517-2526.

Shimono H, Kaida A, Homma H, Nojima H, Onozato Y, Harada H, Miura M. Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency Sci Rep. 2020.11; 10 (1): 20873 (Open access).

Nishimura T, Nakamura Y, Kinoshita N, Yamamoto K, Sasaki Y, Akiyoshi K. Biocatalytic Hybrid Films Self-Assembled from Carbohydrate Block Copolymers and Polysaccharides for Enzyme Prodrug Therapy ACS Appl Bio Mater. 2020.11; 3 (12): 8865-8871.

Uesugi A, Tsushima F, Kodama M, Kuroshima T, Sakurai J, Harada H. Oral granuloma in a pediatric patient with chronic graft-versus-host disease: A case report World J Clin Cases. 2020.11; 8 (22): 5663-5669.

Takei J, Kaneko MK, Ohishi T, Hosono H, Nakamura T, Yanaka M, Sano M, Asano T, Sayama Y, Kawada M, Harada H, Kato Y. A defucosylated anti-CD44 monoclonal antibody 5-mG2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Oncol Rep. 2020.11; 44 (5): 1949-1960.

Hosono H, Takei J, Ohishi T, Sano M, Asano T, Sayama Y, Nakamura T, Yanaka M, Kawada M, Harada H, Kaneko MK, Kato Y. Anti-EGFR monoclonal antibody 134-mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Int J Mol Med. 2020.10; 46 (4): 1443-1452.

Kayamori K, Tsuchiya M, Michi Y, Kuribayashi A, Mikami T, Sakamoto K, Yoda T, Ikeda T. Primordial odontogenic tumor occurred in the maxilla with unique calcifications and its crucial points for differential diagnosis Pathol Int. 2020.10; 71 (1): 80-87.

Kaneko MK, Ohishi T, Nakamura T, Inoue H, Takei J, Sano M, Asano T, Sayama Y, Hosono H, Suzuki H, Kawada M, Kato Y. Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies Monoclon Antib Immunodiagn Immunother. 2020.10; 39 (5): 167-174.

Tsuchihashi H, Naruse T, Yanamoto S, Okuyama K, Furukawa K, Omori K, Umeda M. Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab-resistant oral squamous cell carcinoma. Oncol Rep. 2020.09; 44 (3): 863-872.

Hirai H, Ohsako T, Kugimoto T, Tomioka H, Michi Y, Kayamori K, Yoda T, Miura M, Yoshimura R, Harada H. Comparison of 50- and 66-Gy total irradiation doses for postoperative cervical treatment of patients with oral squamous cell carcinoma Oral Oncol. 2020.08; 107 104708.

Shibata E, Morita KI, Kayamori K, Maruiwa M, Michi Y, Sato Y, Takeuchi K, Ikeda T, Harada H, Yoda T. Secretory carcinoma around Stensen's duct misdiagnosed as salivary duct cyst Int J Clin Exp Pathol. 2020.08; 13 (8): 2211-2217.

Asano T, Sano M, Takei J, Sayama Y, Kaneko MK, Kato Y. Epitope mapping of the anti-diacylglycerol kinase monoclonal antibody DhMab-4 for immunohistochemical analysis Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 117-122.

Takei J, Ohishi T, Kaneko MK, Harada H, Kawada M, Kato Y. A defucosylated anti-PD-L1 monoclonal antibody 13-mG 2a-f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma Biochem Biophys Rep. 2020.08; 30 (24): 100801.

Kaneko MK, Sano M, Takei J, Asano T, Sayama Y, Hosono H, Kobayashi A, Konnai S, Kato Y. Development and Characterization of Anti-Sheep Podoplanin Monoclonal Antibodies PMab-253 and PMab-260 Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 144-145.

Kato Y, Ohishi T, Takei J, Nakamura T, Kawada M, Kaneko MK. An Antihuman Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H2Mab-19) Exerts Antitumor Activity in Glioblastoma Xenograft Models Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 135-139.

Kato Y, Ohishi T, Takei J, Nakamura T, Sano M, Asano T, Sayama Y, Hosono H, Kawada M, Kaneko MK. An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H 2 Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer Xenografts Monoclon Antib Immunodiagn Immunother. 2020.08; 39 (4): 123-128.

Kinoshita N, Sasaki Y, Marukawa E, Hirose R, Sawada SI, Harada H, Akiyoshi K. Crosslinked nanogel-based porous hydrogel as a functional scaffold for tongue muscle regeneration J Biomater Sci Polym Ed. 2020.07; 31 (10): 1254-1271.

Yamada SI, Hasegawa T, Okuyama K, Yamakawa N, Okura M, Hashidume M, Yanamoto S, Akashi M, Kirita T, Umeda M, Kurita H. Clinical significance of the G8 screening tool in elderly patients with oral squamous cell carcinoma Clin Oral Investig. 2020.06; 24 (6): 1953-1961.

Kato Y, Takei J, Sano M, Asano T, Sayama Y, Uchida K, Nakagawa T, Kaneko MK. Detection of lion podoplanin using the anti-tiger podoplanin monoclonal antibody PMab-231 Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 91-94.

Kato Y, Furusawa Y, Sano M, Takei J, Nakamura T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Asano T, Sayama Y, Kaneko MK. Development of an Anti-Sheep Podoplanin Monoclonal Antibody PMab-256 for Immunohistochemical Analysis of Lymphatic Endothelial Cells Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 82-90.

Sayama Y, Sano M, Asano T, Furusawa Y, Takei J, Nakamura T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Nakamura Y, Yanagawa M, Kaneko MK, Kato Y. Epitope mapping of PMab-241, a lymphatic endothelial cell-specific anti-bear podoplanin monoclonal antibody Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 77-81.

Takagawa Y , Gen Y, Muramatsu T, Tanimoto K, Inoue J, Harada H, Inazawa J . miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway Mol ther. 2020.06; 28 (6): 1494-1505.

Kato Y, Ohishi T, Sano M, Asano T, Sayama Y, Takei J, Kawada M, Kaneko MK. H2Mab-19 Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody Therapy Exerts Antitumor Activity in Pancreatic Cancer Xenograft Models Monoclon Antib Immunodiagn Immunother. 2020.06; 39 (3): 61-65.

Kashima Y, Nishii N, Tachinami H, Furusawa E, Nagai S, Harada H, Azuma M. Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8+ T cells and regulatory T cell-dominance, compared to skin SCC. Biochem Biophys Res Commun. 2020.05; 526 (1): 218-224.

Shimamoto H, Hirota Y, Kashima Y, Kinoshita N, Yokokawa M, Ikeda T, Harada H. Granulocyte colony-stimulating factor-producing squamous cell carcinoma of the tongue exhibiting characteristic fluorine-18 deoxyglucose accumulation on positron emission tomography–computed tomography: A case report World J Clin Case. 2020.05; 8 (9): 1666-1673.

Naruse T, Yanamoto S, Okuyama K, Ohmori K, Tsuchihashi H, Furukawa K, Yamada SI, Umeda M. Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence Pathol Oncol Res. 2020.04; 26 (2): 735-742.

Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y. H2Mab-19, an anti-human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts Exp Ther Med. 2020.04; 20 (2): 846-853.

Kato Y, Ito Y, Ohishi T, Kawada M, Nakamura T, Sayama Y, Sano M, Asano T, Yanaka M, Okamoto S, Handa S, Komatsu Y, Takei J, Kaneko MK. Antibody–drug conjugates using mouse–canine chimeric anti-dog podoplanin antibody exerts antitumor activity in a mouse xenograft model Monoclon Antib Immunodiagn Immunother. 2020.04; 39 (2): 37-44.

Yamada S, Kaneko MK, Sayama Y, Asano T, Sano M, Yanaka M, Nakamura T, Okamoto S, Handa S, Komatsu Y, Nakamura Y, Furusawa Y, Takei J, Kato Y. Development of novel mouse monoclonal antibodies against human CD19 Monoclon Antib Immunodiagn Immunother. 2020.04; 39 (2): 45-50.

Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y. A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity Oncol Lett. 2020.04; 19 (4): 2809-2816.

Ohsako T, Shimamoto H, Tomioka H, Hirai H, Kuroshima T, Mochizuki Y, Kugimoto T, Tsushima F, Nakamura S, Kurabayashi T, Harada H. Detection of extraoral primary cancers by positron emission tomography/computed tomography in patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020.03; 129 (3): 272-276.

Yokokawa M, Morita KI, Oikawa Y, Kayamori K, Sakamoto K, Ikeda T, Harada H. Co‐expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma J Oral Pathol Med. 2020.03; 49 (3): 235-242.

Yahara H, Horita S, Yanamoto S, Kitagawa Y, Asaka T, Yoda T, Morita K, Michi Y, Takechi M, Shimasue H, Maruoka Y, Kondo E, Kusukawa J, Tsujiguchi H, Sato T, Kannon T, Nakamura H, Tajima A, Hosomichi K, Yahara K. A Targeted Genetic Association Study of the Rare Type of Osteomyelitis J Dent Res. 2020.03; 99 (3): 271-276.

Yamamoto D, Kayamori K, Sakamoto K, Tsuchiya M, Ikeda T, Harada H, Yoda T, Watabe T, Hara-Yokoyama M. Intracellular claudin-1 at the invasive front of tongue squamous cell carcinoma is associated with lymph node metastasis Cancer Sci. 2020.02; 111 (2): 700-712.

Nguyen CTK, Sawangarun W, Mandasari K, Morita KI, Harada H, Kayamori K, Yamaguchi A, Sakamoto K. AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression PLoS ONE. 2020.02; 15 (2): e0222689.

Yukimori A, Tsuchiya M, Wada A, Michi Y, Kayamori K, Sakamoto K, Ikeda T. Genetic and histopathological analysis of a case of primary intraosseous carcinoma, NOS with features of both ameloblastic carcinoma and squamous cell carcinoma World J Surg Oncol. 2020.02; 18 (1): 45.

Nojima H, Homma H, Onozato Y, Kaida A, Harada H, Miura M. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells Exp Cell Res. 2020.01; 388 (2):

Kagifuku Y, Tohara H, Wakasugi Y, Susa C, Nakane A, Toyoshima M, Nakakuki K, Kabasawa Y, Harada H, Minakuchi S. What Factors Affect Changes in Body Composition and Swallowing Function in Patients Hospitalized for Oral Cancer Surgery? Clin Interv Aging. 2020.01; 15 1-7.

Oikawa Y, Michi Y, Tsushima F, Tomioka H, Mochizuki Y, Kugimoto T, Osako T, Nojima H, Yokokawa M, Kashima Y, Harada H. Management of retropharyngeal lymph node metastasis in oral cancer. Oral Oncology. 2019.12; 99

Kojima Y, Kawaoka Y, Sawada S, Hayashida S, Okuyama K, Yutori H, Kawakita A, Ishida S, Soutome S, Yanamoto S, Umeda M, Iwai H.. Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. Journal of Bone and Mineral Metabolism. 2019.09; 37 (5): 913-919.

Xia Y, Ohno T, Nishii N, Bhingare A, Tachinami H, Kashima Y, Nagai S, Saito H, Nakae S, Azuma M. Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model Biochemical and Biophysical Research Communications. 2019.08; 518 (2): 331-336.

Okuyama K, Naruse T, Yutori H, Yanamoto S, Umeda M.. Oral surgery in patients with antiphospholipid syndrome. Journal of Oral Science. 2019.08; 61 (3): 386-390.

Suzuki N, Kuribayashi A, Sakamoto K, Sakamoto J, Nakamura S, Watanabe H, Harada H, Kurabayashi T. Diagnostic abilities of 3T MRI for assessing mandibular invasion of squamous cell carcinoma in the oral cavity: comparison with 64-row multidetector CT. Dento maxillo facial radiology. 2019.05; 48 (4): 20180311.

Tachinami H, Nishii N, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Tomihara K, Noguchi M, Azuma M. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade. Oral Oncology. 2019.04; 91 21-28.

Okuyama K, Fukushima H, Naruse T, Yanamoto S, Tsuchihashi H, Umeda M.. CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis. Pathology and Oncology Research. 2019.04; 25 (2): 603-609.

Tomioka H, Mochizuki Y, Ohsako T, Hirai H, Shimamoto H, Harada H.. Buccinator and Mandibular Node Metastases in Oral Squamous Cell Carcinoma. Journal of oral and maxillofacial surgery. 2019.04; 77 (4): 867-873.

Higuchi Y, Tsushima F, Sumikura K, Sato Y, Harada H, Kayamori K, Ikeda T.. Diagnosis and treatment of oral focal mucinosis: a case series. Journal of Medical Case Reports. 2019.04; 13(1) (108): Published online.

Tomioka H, Mochizuki Y, Ohsako T, Hirai H, Shimamoto H, Harada H.. Buccinator and Mandibular Node Metastases in Oral Squamous Cell Carcinoma Journal of oral and maxillofacial surgery. 2019.04; 77 (4): 867-873.

Fukuda S, Akiyama M, Harada H, Nakahama KI.. Effect of gap junction-mediated intercellular communication on TGF-β induced epithelial-to-mesenchymal transition. Biochem Biophys Res Commun.. 2019.01; 508 (3): 928-933.

Takada Kaho, Kuroshima Takeshi, Shimamoto Hiroaki, Ohsako Toshimitsu, Kayamori Kou, Ikeda Tohru, Harada Hiroyuki. Metastasis of lower gingival squamous cell carcinoma to buccinator lymph node: case report and review of the literature WORLD JOURNAL OF SURGICAL ONCOLOGY. 2019.01; 17 (1): 13.

Shimizu R, Tanaka K, Oikawa Y, Tomioka H, Kayamori K, Ikeda T, Yoshioka T, Ebihara A, Harada H. Epithelioid cell granuloma with caseating necrosis possibly caused by periapical periodontitis: a case report. Journal of Medical Case Reports.. 2018.12; 12 (1): 365-370.

Yamada S, Itai S, Furusawa Y, Sano M, NakamuraT, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Fukui M, Harada H, Mizuno T, Sakai Y, Ogasawara S, Murata T, Uchida H, Tahara H, Kaneko MK, Kato Y. Detection of tiger podoplanin using the anti-cat podoplanin monoclonal antibody PMab-52 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.11;

Furusawa Y, Yamada S, Itai S, Sano M, Nakamura T, Yanaka M, Handa S, Mizuno T, Maeda K, Fukui M, Harada H, Kaneko MK, Kato Y. Establishment of Monoclonal Antibody PMab-202 against Horse Podoplanin Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.11;

Takahashi Y, Tanaka K, Hirai H, Marukawa E, Izumo T, Harada H. Appropriate surgical margin for odontogenic myxoma: a review of 12 cases. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2018.11; 126 (5): 404-408.

Mochizuki Y, Harada H, Yokokawa M, Kinoshita N, Kubota K, Okado T, Fukayama H. Oral and maxillofacial surgery in patients undergoing dialysis for advanced renal disease: report of five cases. BMC Oral Health. 2018.10; 18 166-175.

Yamada I, Yoshino N, Hikishima K, Sakamoto J, Yokokawa M, Oikawa Y, Harada H, Kurabayashi T, Saida Y, Tateishi U, Yukimori A, Izumo T, Asahina S. Oral carcinoma: Clinical evaluation using diffusion kurtosis imaging and its correlation with histopathologic findings Magnetic Resonance Imaging. 2018.09; 51 69-78.

Ngamsom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible Oral radiology. 2018.09; 34 (3): 257-261.

Itai S, Yamada S, Kaneko MK, Sano M, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Furusawa Y, Fukui M, Ohishi T, Kawada M, Harada H, Kato Y. Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2 Biochem Biophys Rep. 2018.09;

Kaneko MK, Yamada S, Itai S, Furusawa S, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Fukui M, Harada H, Kato Y. Epitope mapping of an anti-alpha thalassemia/mental retardation syndrome Xlinked monoclonal antibody AMab-6 Biochem Biophys Rep. 2018.09;

Matsui T, Okada T, Kawada K, Okuda m, Ogo T, Nakajima Y, Kume Y, Ryotokuji T, Hoshino A, Tokairin Y, Michi Y, Harada H, Nakajima Y, Kawano T. Detection of second primary malignancies of the esophagus and hypophraynx in oral squamous cell carcinoma patients Laryngoscope Investigative Otolaryngology. 2018.08; 3 (4): 263-267.

Yamaga E, Toriihara A, Nakamura S, Asai S, Fujioka T, Yoshimura R, Michi Y, Harada H, Tateishi U. Clinical usefulness of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0) Japanese Journal of Clinical Oncology. 2018.07; 48 (7): 633-639.

Shimada Y, Kawasaki Y, Tayama M, Kindaichi J, Maruoka Y. A case of central odontogenic fibroma of the mandible in a nevoid basal cell carcinoma syndrome patient Oral Science International. 2018.07; 15 (2): 61-67.

Yamada S, Kaneko MK, Itai S, Chang YW, Nakamura T, Yanaka M, Ogasawara S, Murata T, Uchida H, Tahara H, Harada H, Kato Y. Epitope Mapping of Monoclonal Antibody PMab-48 against Dog Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.06;

Ohata Y, Kayamori K, Yukimori A, Sumikura K, Ohsako T, Harada H, Sakamoto K, Ikeda T. A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation. Pathology International. 2018.05; 68 (5): 307-312.

Miyazaki H, Ohshiro T, Romeo U, Noguchi T, Maruoka Y, Gaimari G, Tomov G, Wada Y, Tanaka K, Ohshiro T, Asamura S. Retrospective Study on Laser Treatment of Oral Vascular Lesions Using the "Leopard Technique": The Multiple Spot Irradiation Technique with a Single-Pulsed Wave Photomed Laser Surgery. 2018.05; 36 (6): 320-325.

Furusawa Y, Yamada Y, Itai S, Nakamura T, Fukui M, Harada H, Kaneko MK, Kato Y. Elucidation of critical epitope mapping of anti-rat podoplanin monoclonal antibody PMab-2 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.05;

Kaneko MK, Yamada S, Itai S, Chang YW, Nakamura T, Yanaka M, Harada H, Suzuki H, Kato Y. Elucidation of The TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.05;

Itai S, Ohishi T, Kaneko MK, Yamada S, Abe S, Nakamura T, Yanaka M, Chang YW, Ohba S, Nishioka Y, Kawada M, Harada H, Kato Y. Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma. Oncotarget. 2018.04;

Sato M, Harada H, Nagata C, Suzuki K. A case of Ectomesenchymal Chondromyxoid Tumor on the tongue Journal of Oral and Maxillofacial Surgery, Medicine. 2018.03; 30 (2): 134-137.

Jiaranuchart S, Kaida A, Onozato Y, Harada H, Miura M. DNA damage response following X-irradiation in oral cancer lines HSC3 and HSC4 Archives of Oral Biology. 2018.02; 90 1-8.

Nishii N, Tachinami H, Kondo Y, Xia Y, Kashima Y, Ohno T, Nagai S, Li L, Lau W, Harada H, Azuma M. Systemic administration of a TLR7 agonist attenuates regulatory T cells by dend+E11:AB11ritic cell modification and overcomes resistance to PD-L1 blockade therapy Oncotarget. 2018.01; 9 13301-13312.

Takemoto T, Kabasawa Y, Higuchi Y, Tabata Y, Aoki K, Tamura Y, Harada H. Combination of the RANKL-binding peptide W9 and bFGF induces ectopic bone regeneration in the rat calvarial defect mode Dental, Oral and Craniofacial Research. 2017.12; 4 (3): 2-7.

Itai S, Yamada S, Kaneko MK, Harada H, Kagawa Y, Konnai S, Kato Y. Expression of cat podoplanin in feline squamous cell carcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11;

Yamada S, Itai S, Nakamura T, Chang YW, Harada H, Suzuki H, Kaneko MK, Kato Y. Establishment of H2Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11;

Itai S, Yamada S, Kaneko MK, Chang YW, Harada, H, Kato Y. Establishment of EMab-134, a sensitive and specific anti-epidermal growth factor receptor monoclonal antibody for detecting squamous cell carcinoma cells of the oral cavity Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.11;

Ohata Y, Tatsuzawa A, Ohyama Y, Ichikawa A, Mochizuki Y, Ishibashi S, Itakura Y, Sakamoto K, Ikeda T, Kitagawa M, Yamamoto K. A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer Human Pathology. 2017.11; 69 129-139.

Itai S, Kaneko MK, Fujii Y, Yamada S, Nakamura T, Yanaka M, Saidoh N, Handa S, Chang YW, Suzuki H, Harada H, Kato Y. Development of EMab-51, a Sensitive and Specific Anti-EGFR Monoclonal Antibody in Western Blot and Immunohistochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10;

Yamada S, Itai S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Harada H, Kagawa Y, Ichii O, Konnai S, Kaneko MK, Kato Y. PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10;

Itai S, Yamada S, Kaneko MK, Harada H, Kato Y. Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.10;

Yamagata Y, Tomioka H, Sakamoto K, Sato K, Harada H, Ikeda T, Kayamori K. CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma J Oral Maxillofac Surg. 2017.10; 75 (10): 2144-2153.

Hirai H, Tomioka H, Mochizuki Y, Oikawa Y, Tsushima F, Harada H. Clinical Course of Oral Squamous Cell Carcinoma in Patients on Immunosuppressant and Glucocorticoid Therapy J Oral Maxillofac Surg. 2017.09; 75 (9):

Takahara N, Nakagawa S, Sumikura K, Kabasawa Y, Sakamoto I, Harada H. Association of TMJ pain according to magnetic resonance imaging findings in TMD patients J Oral Maxillofac Surg. 2017.09; 75 (9): 1848-1855.

Itai S, Fujii Y, Kaneko MK, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Takahashi M, Suzuki H, Harada H, Kato Y. H2Mab-77 is a sensitive and specific anti-HER2 monoclonal antibody against breast cancer Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08;

Nakano T, Ogasawara S, Tanaka T, Hozumi Y, Mizuno S, Satoh E, Sakane F, Okada N, Taketomi A, Honma R, Nakamura T, Saidoh N, Yanaka M, Itai S, Handa S, Chang YW, Yamada S, Kaneko MK, Kato Y, Goto K. DaMab-2: Anti-Human DGK Monoclonal Antibody for immunocytochemistry Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08;

Kaneko MK, Kunita A, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Ogasawara S, Ohishi T, Abe S, Itai S, Harada H, Kawada M, Nishioka Y, Fukayama M, Kato Y. Anti-Podocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2017.08;

Shimamoto H, Oikawa Y, Osako T, Hirai H, Mochizuki Y, Tanaka K, Tomioka H, Harada H. Neck failure after elective neck dissection in patients with oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol. 2017.07; 124 (1): 32-36.

Yukimori A, Oikawa Y, Morita KI, Nguyen CTK, Harada H, Yamaguchi S, KayamoriK, Yamaguchi A, Ikeda T, Sakamoto K. Genetic basis of calcifying cysticodontogenic tumors PLoS One. 2017.06; 12 (6):

Mochizuki Y, Harada H, Shimamoto H, Tomioka H, Hirai H. Multiple Free Flap Reconstructions of Head and Neck Defects Due to Oral Cancer Plast Reconstr Surg Glob Open. 2017.06; 5 (6):

Nguyen CT，Okamura T， Morita K，Yamaguchi S，Harada H，Miki Y，Izumo T，Kayamori K，Yamaguchi A，Sakamoto K. LAMC2 is a predictive marker for the malignant progression of leukoplakia Journal of Oral Pathology and Medicine. 2017.03; 46 (3): 223-231.

Shimada Y, Nakagawa Y, Ide K, Sato I, Hagiwara S, Yamada H, Kawasaki Y, Maruoka Y. Clinical importance of elimination of potential dental focal infection before the first cycle of chemotherapy in patients with hematologic malignancy. Support Care Cancer. 2017.02;

Kaneko MK，Nakamura T，Honma R，Ogasawara S，Fujii Y，Abe S，Takagi M，Harada H，Suzuki H，Nishioka Y，Kato Y. Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin using glycan-deficient cell lines generated by CRISPR/Cas and TALEN Cancer Medicine. 2017.01; 6 (2): 382-396.

Takahara N，Kabasawa Y，Sato M，Tetsumura A，Kurabayashi T，Omura K. MRI Changes of temporomandibular joint following mandibular setback using sagittal split ramus osteotomy with rigid fixation The Journal of Craniomandibular & Sleep Practice. 2017.01; 35 (11): 38-45.

Lam PD, Kuribayashi A, Sakamoto J, Nakamura S, Harada H, Kurabayashi T. Imaging findings of childhood B-cell lymphoblastic lymphoma in the mental region: a case report. Dentomaxillofacial Radiology. 2017;

Macedo R，Rochefort J，Guillot-Delost M，Tanaka K，Le Moignic A，Noizat C，Baillou C，Mateo V，Carpentier AF，Tartour E，Bertolus C，Bellier B，Lescaille G，Lemoine FM. Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles Oncoimmunology. 2016.07; 5 (7): e1164363.

Kohmoto T，Tsuji A，Morita K，Naruto T，Masuda K，Kashimada K，Enomoto K，Morio T，Harada H，Imoto I. A novel COL11A1 missense mutation in siblings with non-ocular Stickler syndrome Human Genome Variation. 2016.04; 2016 (3): 16003.

Kayamori K，Katsube K，Sakamoto K，Ohyama Y，Hirai H，Yukimori A，Ohata Y，Akashi T，Saitoh M，Harada K，Harada H，Yamaguchi A. NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma PLoS One. 2016.04; 11 (4): e0154112.

Oda S，Nozawa T，Nozawa-Minowa A，Tanaka M，Aikawa C，Harada H，Nakagawa I. Golgi-Resident GTPase Rab30 Promotes the Biogenesis of Pathogen-Containing Autophagosomes PLoS One. 2016.01; 11 (1): e0147061.

Masanori Kudoh, Ken Omura, Arata Satsukawa, Koshi Matsumoto, Takahide Taguchi, Hiroyuki Harada, Yoshimasa Ishii. Symmetric Lipomatosis Arising in the Tongue Presenting as Macroglossia and Articulatory Disorder Case Reports in Otolaryngology. 2016; (2016):

Ohata Y，Tohyama R，Kayamori K，Shimamoto H，Hirota Y，Harada H，Izumo T，Sakamoto K. A rare cancer of the tongue that demonstrated unusual histology and immunohistochemical phenotype: case report International Dentistry Scientific Meeting 2016/UI Proceedings on Health and Medicine. 2016; 1 (1): 172-175.

Masaru S，Morita K，Kabasawa Y，Harada H. Bilateral nasolabial cysts: a case report Jounal of Medical case Reports. 2016; 10 246.

Kudoh M, Harada H, Sato Y, Omura K, Ishii Y. Massive odontoameloblastoma arising in the maxilla: a case report. J Medical Case Rep. 2015.12; 9 278.

Kuribayashi Y, Tsushima F, Morita K, Matsumoto K, Sakurai J, Uesugi A, Sato K, Oda S, Sakamoto K, Harada H. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol. 2015.11; 51 (11): 1020-1025.

Morita K, Naruto T, Tanimoto K, Yasukawa C, Oikawa Y, Masuda K, Imoto I, Inazawa J, Omura K, Harada H. Simultaneous detection of both single nucleotide variations and copy number alterations by next-generation sequencing in gorlin syndrome. PLOS One. 2015.11; 10 (11): e0140480.

Kudo M, Harada H, Matsumoto K, Sato Y, Omura K, Ishii Y. Massive neurilemoma of the hard plate in which preoperative diagnosis was difficult. Case Rep Surg. 2015.08; 2015 638025.

Tomioka H, Kaneoya A, Mochizuki Y, Harada H. Primary diffuse large B-cell lymphoma arising in the tongue accompanied by ataxia-telangiectasia: a case report. J Clin Diagn Res. 2015.06; 9 (6): ZD25-ZD27.

清水六花, 大迫利光, 釘本琢磨, 西井直人, 津島文彦, 原田浩之. 多様な口腔症状を呈したSotos症候群の1例 日本口腔外科学会雑誌. 2023.01; 69 (1): 22-26.

佐藤 昌, 伊澤和倫, 平井秀明, 原田浩之.. 顎口腔領域の転移性腫瘍6例の臨床病理学的検討. 日本口腔腫瘍学会誌. 2022.09; 34 (3): 123-129.

新垣理宣, 勝良剛詞, 小林大二郎, 道 泰之, 北本佳住, 依田哲也, 倉林 亨. 頭頸部化学放射線治療後に多発う蝕を生じ口腔管理に苦慮した1例 歯科放射線. 2022.03; 61 (2): 53-57.

小宮瑠里. 口腔内症状を契機に診断されたHIV感染症の1例 山梨県立中央病院年報. 2022.03; 48 160-163.

遠山皓基, 加納嘉人, 野地理夏, 青柳康子, 松寺翔太郎, 大野十央, 有泉陽介, 道泰之, 富岡寛文, 島本裕彰, 吉村 亮一, 朝蔭孝宏, 原田浩之, 三宅智, 三浦雅彦, 池田貞勝. 再発・転移頭頸部癌に対する網羅的がんゲノム解析と臨床的有用性. 頭頸部癌. 2021.12; 47 (4): 359-365.

柴田恵里, 奥山紘平, 道 泰之, 坂本 啓, 原田浩之, 依田哲也. 肺転移に対し外科療法を行った下顎骨原発骨肉腫の1例. 日口外学誌. 2021.06; 67 (6): 353-358.

家村綾子，柳町昌克，田崎彰久，廣田由佳，大西威一郎，神谷尚宏，津島文彦，原田浩之，木下伊寿美，孝橋賢一，小田義直，高木正稔，明石 巧，朝蔭孝宏，森尾友宏. 出生時から開口障害を認めたデスモイド型線維腫症. 日小児会誌. 2021.04; 125 (4): 619-624.

土橋宏輝, 鳴瀬智史, 奥山紘平, 古川浩平, 柳本惣市, 梅田正博. 放射線性顎骨骨髄炎により広範な皮膚壊死を生じた壊死性筋膜炎の1例 日口診誌. 2020.06; 33 (2): 153-159.

田中美佐子, 富岡寛文, 高原楠旻, 畠山一郎, 坂本 啓, 原田浩之. オトガイ部に発生した結節性筋膜炎の１例 日口外誌. 2020.06; 66 (6): 292-297.

木村 敦, 平井秀明, 下野宏晃, 坂本 啓, 原田浩之, 依田哲也. 下顎骨関節突起に転移した甲状腺癌の1例 日口外誌. 2020.04; 66 (4): 200-205.

丸川恵理子, 立川敬子, 望月裕美, 高橋幸伸, 原田浩之, 春日井昇平. 巨大な下顎骨エナメル上皮腫摘出後にインプラント治療を行なった1例 顎顔面インプラント誌. 2020.04; 19 (1): 13-18.

小井田奈美、西井直人、渡邉峻介、小山敏雄. 口腔扁平上皮癌におけるPolo-like kinase1(Plk1)の発現解析 山梨中病年報. 2020.03; 46 164-167.

小井田奈美、三澤常美、西井直人、高橋幸伸. 当科28年間の悪性腫瘍症例の臨床的検討 山梨中病年報. 2020.03; 46 157-163.

奥山紘平, 柳本惣市, 鳴瀬智史, 梅田正博. 人工透析患者に生じたセフトリアキソン関連脳症の1例 日口診誌. 2020.02; 33 (1): 43-46.

古川浩平, 鳴瀬智史, 奥山紘平, 柳本惣市, 片瀬直樹, 梅田正博. 下顎前歯部に発生した腺性歯原性嚢胞の１例 日口診誌. 2020.02; 33 (1): 61-65.

原田 浩之, 富岡 寛文, 横川 美咲, 野島 瞳, 小宮 瑠里, 栢森 高, 池田 通, 倉林 亨. 新TNM分類(第8版)の改定点と問題点 舌癌における新T分類(UICC第8版)に導入された深達度(DOI)評価 標本収縮を考慮した病理組織学的DOIと臨床的DOI評価の検討 頭頸部癌 . 2019.04; 45 (1): 1-7.

濱本 正太郎, 富岡 寛文, 横川 美咲, 生田 稔, 坂本 啓, 原田 浩之. 多発性骨髄腫に移行した下顎骨孤立性形質細胞腫の1例 日本口腔外科学会雑誌. 2019.02; 65 (2): 110-114.

原田浩之. 口腔癌における選択的頸部郭清術 日本口腔外科学会雑誌. 2018.01; 64 (1): 8-12.

小村 健, 原田 浩之, 生田 稔, 島本 裕彰, 富岡 寛文, 釘本 琢磨. 進行口腔原発巣再発癌（rT3，rT4）に対する救済手術 日本口腔腫瘍学会誌. 2014.12; 26 (4): 132-139.

森 正次, 樋口 佑輔, 相澤 悟. 2次性メトヘモグロビン血症の既往を持つ患者の抜歯の1例 日本口腔診断学会雑誌. 2014.10; 27 (3): 307-310.

釘本 琢磨, 小村 健, 田中 香衣, 富岡 寛文, 島本 裕彰, 原田 浩之. PGAシートとフィブリン糊併用の有茎頬脂肪体による上顎部分切除後の上顎・口蓋再建 日本口腔外科学会雑誌. 2014.09; 60 (9): 527-531.

原田 浩之, 小村 健, 島本 裕彰. 口腔扁平上皮癌における選択的頸部郭清術 頭頸部癌. 2014.04; 40 (1): 16-22.

田口 貴英. 口腔扁平上皮癌におけるEGFレセプターの核内移行と臨床病理学的因子との関連 口腔病学会雑誌. 2014.03; 81 (1): 45-52.

工藤 雅範, 原田 浩之, 津島 文彦, 松本 佳奈子, 小村 健, 石井 良昌. 上顎洞を広範に占拠した内反乳頭腫の1例 日本口腔外科学会雑誌. 2014.01; 60 (1): 29-33.